(Q33767845)

29 July 2017

4 references

25 April 2019

19 June 2019

20 August 2019

19 November 2020

Blood biomarkers for amyotrophic lateral sclerosis: myth or reality? (English)

1 reference

amyotrophic lateral sclerosis

29 July 2017

1 reference

19 November 2020

5 references

25 April 2019

19 June 2019

20 August 2019

20 September 2020

19 November 2020

physiological phenomenon

1 reference

20 August 2019

0 references

Laura Robelin

1

1 reference

29 July 2017

Jose Luis Gonzalez De Aguilar

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

2 June 2014

5 references

BioMed Research International

29 July 2017

25 April 2019

19 June 2019

20 August 2019

19 November 2020

5 references

29 July 2017

25 April 2019

19 June 2019

20 August 2019

19 November 2020

2014

1 reference

29 July 2017

page(s)

525097

1 reference

Creative Commons Attribution 3.0 Unported

29 July 2017

copyright license

4 references

25 April 2019

19 June 2019

20 August 2019

on focus list of Wikimedia project

19 November 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Lessons of ALS imaging: Pitfalls and future directions - A critical review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Blood-CNS Barrier Impairment in ALS patients versus an animal model

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

More than a bystander: the contributions of intrinsic skeletal muscle defects in motor neuron diseases.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

ALS and oxidative stress: the neurovascular scenario

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

25 years of neuroimaging in amyotrophic lateral sclerosis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Eosinophil-derived neurotoxin is elevated in patients with amyotrophic lateral sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Electrodiagnosis in Persons With Amyotrophic Lateral Sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

The changing scene of amyotrophic lateral sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

CSF markers in amyotrophic lateral sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Serum caspase-9 levels are increased in patients with amyotrophic lateral sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Microarray analysis of peripheral blood lymphocytes from ALS patients and the SAFE detection of the KEGG ALS pathway

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Mitochondrial dysfunction in ALS.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Energy metabolism in amyotrophic lateral sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Association between blood lead and the risk of amyotrophic lateral sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Oxidative stress in ALS: key role in motor neuron injury and therapeutic target

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Biomarkers in amyotrophic lateral sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Metabolomic analysis and signatures in motor neuron disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Motor unit number estimation in neuromuscular disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Protein biomarkers for amyotrophic lateral sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Clinical care of patients with amyotrophic lateral sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Diagnostic investigation and multidisciplinary management in motor neuron disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

28 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Protein aggregation in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Axonal degeneration in the peripheral nervous system: implications for the pathogenesis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Bayesian statistical MUNE method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Reduced expression of metabotropic glutamate receptor 2mRNA in T cells of ALS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Elevated cerebrospinal fluid and plasma homocysteine levels in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Oxidant-antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Time course of oxidant markers and antioxidant defenses in subgroups of amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Red cell superoxide dismutase activity in sporadic amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Raised nitrate concentration and low SOD activity in the CSF of sporadic ALS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Elevated inflammatory markers in a group of amyotrophic lateral sclerosis patients from northern India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Plasma biomarkers associated with ALS and their relationship to iron homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Possible association between expression of chemokine receptor-2 (CCR2) and amyotrophic lateral sclerosis (ALS) patients of North India

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

TNF and sTNFR1/2 plasma levels in ALS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Elevated serum angiogenin levels in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Creatine kinase activity in amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Serum N-acetylaspartate level in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: a possible use as an indicator of extent of the motor neuron loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Does apolipoprotein E genotype modify the clinical expression of ALS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Serum anti-Fas antibody levels in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Axonal damage markers in cerebrospinal fluid are increased in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

pNfH is a promising biomarker for ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

TDP-43 plasma levels are higher in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

The future of blood-based biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Biochemical alterations associated with ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Serum soluble OX40 in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Evaluation of matrix metalloproteinases in serum of patients with amyotrophic lateral sclerosis with pattern recognition methods.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060749

Neuroimaging in amyotrophic lateral sclerosis

30 October 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Decrease of S100 beta protein in serum of patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Metal Concentrations in Cerebrospinal Fluid and Blood Plasma from Patients with Amyotrophic Lateral Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F525097

Reproducibility of MUNIX in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

12 December 2020

Alterations of T cell subsets in ALS: a systemic immune activation?

1 reference

12 December 2020

Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis

1 reference

12 December 2020

Increased serum CNTF level in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Dyslipidemia is a protective factor in amyotrophic lateral sclerosis

1 reference

12 December 2020

Biotransformation of nitric oxide in the cerebrospinal fluid of amyotrophic lateral sclerosis patients

1 reference

12 December 2020

Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients

1 reference

12 December 2020

Muscle gene expression is a marker of amyotrophic lateral sclerosis severity

1 reference

12 December 2020

Alteration of the Bcl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: evidence for the implication of the p53 signaling pathway

1 reference

12 December 2020

APOE: a potential marker of disease progression in ALS

1 reference

12 December 2020

Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Increased oxidative damage to DNA in ALS patients

1 reference

12 December 2020

Serum type IV collagen increases with duration of amyotrophic lateral sclerosis

1 reference

12 December 2020

Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Serum markers of type I collagen synthesis and degradation in amyotrophic lateral sclerosis

1 reference

12 December 2020

EMMPRIN levels in serum of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Detection by 4-parameter microscopic imaging and increase of rare mononuclear blood leukocyte types expressing the Fc gamma RIII receptor (CD16) for immunoglobulin G in human sporadic amyotrophic lateral sclerosis (ALS)

1 reference

12 December 2020

Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity

1 reference

12 December 2020

Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration

1 reference

12 December 2020

Elevation of serum soluble E-selectin and antisulfoglucuronyl paragloboside antibodies in amyotrophic lateral sclerosis

1 reference

12 December 2020

Decreased serum endoglin level in patients with amyotrophic lateral sclerosis: a preliminary report

1 reference

12 December 2020

Granzymes A and B levels in serum of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress?

1 reference

12 December 2020

Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression

1 reference

12 December 2020

Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis

1 reference

12 December 2020

Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Total antioxidant status is increased in the serum of amyotrophic lateral sclerosis patients

1 reference

12 December 2020

Identifiers

DOI

10.1155/2014/525097

1 reference

29 July 2017

1 reference

29 July 2017

1 reference